Clinical Trial Update: Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

View source ↗

Summary

The NCT01445275 trial on the cost of cancer risk management in women at elevated genetic risk for ovarian cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Carcinoma
• Hereditary Breast and Ovarian Cancer Syndrome
• Ovarian Carcinoma
• Peritoneal Carcinoma

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Carcinoma, Hereditary Breast and Ovarian Cancer Syndrome | Status: WITHDRAWN